🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Cool preprint by ⁦Michael Dustin⁩ and coworkers on how various T cell engager formats, w/varying geometries/rigidities, impact potency Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency | bioRxiv biorxiv.org/content/10.110…

Glad to share our new publication Immunity , reporting a new E-CAR that can form mature immunological synapse through phase separation. Paper link: authors.elsevier.com/a/1kATc_OR%7Ey…

Beautiful illustration of E-CAR T cell👍A new way to engineer CAR T cells. Congrats, Chenqi, Haopeng, and the team👏

Design of high specificity binders for peptide-MHC-I complexes biorxiv.org/cgi/content/sh… #biorxiv_immuno

Great work!

Awesome work. De novo designed pMHC-I binder!!

Thrilled to share our latest work on broadening T cell help for developing better flu vaccines Science Magazine Sarah Ross Grateful for Mark Davis’s invaluable mentorship Stanford Medicine Stanford Immunology buff.ly/4flV5TK 1/n

🎄Just in time for the holidays! Leucine zipper-based purification of CAR-T cells displaying multiple receptors (aka Zip-sort). Congrats to Scott James Marcel van den Brink and co-authors! Parker Institute for Cancer Immunotherapy MSK Department of Medicine Memorial Sloan Kettering Cancer Center City of Hope #Tcellpower rdcu.be/d4AX5

Really glad that our paper has been highlighted. Modified CARs Self-Condense to Form Optimal Immunological Synapses aacrjournals.org/cdnews/news/19…

Just before the New Year: BindCraft v1.5! Please fill out this form to request new features and help us make BindCraft even better. forms.gle/XsGHDCyHtczVba…

Congrats to Yael on this amazing paper!!!

Congrats to Caleb!

Congrats to Juan! Great protein engineering work!

Nice reading! Congrats on this great paper.

I am so excited to be selected as one of the recipients of the Michelson Prize from the Michelson Medical Research Foundation and the Human Immunome Project! This award enables our lab's research at the intersection of systems immunology, virology, and large-scale genomics research.

New results from a phase 1 clinical trial of the messenger RNA (#mRNA)-based therapeutic cancer vaccine autogene cevumeran are now published in the journal nature. The experimental approach to treating #pancreaticcancer continues to show potential to stimulate an immune

Congrats Yael for this amazing work! Yael David

Congrats on this great discovery! Klebanoff_Lab

Very inspiring to hear all the great talks from colleagues! Thanks for organizing such amazing symposium Arthritis National Research Foundation . See you next year in Boston!

Congratulations Gita Abhiraman, so much fun working together on this exciting project 🎉